Interpace Biosciences Statistics
Total Valuation
IDXG has a market cap or net worth of 49.30 million. The enterprise value is 50.14 million.
| Market Cap | 49.30M |
| Enterprise Value | 50.14M |
Important Dates
The next estimated earnings date is Thursday, March 12, 2026.
| Earnings Date | Mar 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
IDXG has 27.70 million shares outstanding. The number of shares has increased by 654.43% in one year.
| Current Share Class | 27.70M |
| Shares Outstanding | 27.70M |
| Shares Change (YoY) | +654.43% |
| Shares Change (QoQ) | +526.16% |
| Owned by Insiders (%) | 3.49% |
| Owned by Institutions (%) | 0.52% |
| Float | 26.73M |
Valuation Ratios
The trailing PE ratio is 16.41.
| PE Ratio | 16.41 |
| Forward PE | n/a |
| PS Ratio | 1.18 |
| PB Ratio | -165.43 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 11.13 |
| P/OCF Ratio | 10.11 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.96, with an EV/FCF ratio of 11.32.
| EV / Earnings | 15.03 |
| EV / Sales | 1.20 |
| EV / EBITDA | 8.96 |
| EV / EBIT | 10.98 |
| EV / FCF | 11.32 |
Financial Position
The company has a current ratio of 1.54
| Current Ratio | 1.54 |
| Quick Ratio | 1.24 |
| Debt / Equity | n/a |
| Debt / EBITDA | 0.40 |
| Debt / FCF | 0.51 |
| Interest Coverage | 17.11 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 21.90% |
| Return on Invested Capital (ROIC) | 462.35% |
| Return on Capital Employed (ROCE) | 75.00% |
| Weighted Average Cost of Capital (WACC) | 9.98% |
| Revenue Per Employee | 377,613 |
| Profits Per Employee | 30,045 |
| Employee Count | 111 |
| Asset Turnover | 3.21 |
| Inventory Turnover | 13.70 |
Taxes
| Income Tax | -1,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +38.74% in the last 52 weeks. The beta is 1.05, so IDXG's price volatility has been similar to the market average.
| Beta (5Y) | 1.05 |
| 52-Week Price Change | +38.74% |
| 50-Day Moving Average | 1.21 |
| 200-Day Moving Average | 0.97 |
| Relative Strength Index (RSI) | 70.23 |
| Average Volume (20 Days) | 14,354 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.01 |
Income Statement
In the last 12 months, IDXG had revenue of 41.92 million and earned 3.34 million in profits. Earnings per share was 0.10.
| Revenue | 41.92M |
| Gross Profit | 25.99M |
| Operating Income | 4.57M |
| Pretax Income | 4.10M |
| Net Income | 3.34M |
| EBITDA | 4.97M |
| EBIT | 4.57M |
| Earnings Per Share (EPS) | 0.10 |
Balance Sheet
The company has 1.42 million in cash and 2.26 million in debt, with a net cash position of -837,000 or -0.03 per share.
| Cash & Cash Equivalents | 1.42M |
| Total Debt | 2.26M |
| Net Cash | -837,000 |
| Net Cash Per Share | -0.03 |
| Equity (Book Value) | -298,000 |
| Book Value Per Share | -0.07 |
| Working Capital | 3.19M |
Cash Flow
In the last 12 months, operating cash flow was 4.88 million and capital expenditures -447,000, giving a free cash flow of 4.43 million.
| Operating Cash Flow | 4.88M |
| Capital Expenditures | -447,000 |
| Free Cash Flow | 4.43M |
| FCF Per Share | 0.16 |
Margins
Gross margin is 62.01%, with operating and profit margins of 10.90% and 9.06%.
| Gross Margin | 62.01% |
| Operating Margin | 10.90% |
| Pretax Margin | 9.77% |
| Profit Margin | 9.06% |
| EBITDA Margin | 11.86% |
| EBIT Margin | 10.90% |
| FCF Margin | 10.57% |
Dividends & Yields
IDXG does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -654.43% |
| Shareholder Yield | -654.43% |
| Earnings Yield | 6.76% |
| FCF Yield | 8.99% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on January 15, 2020. It was a reverse split with a ratio of 0.1.
| Last Split Date | Jan 15, 2020 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
IDXG has an Altman Z-Score of -21.79 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -21.79 |
| Piotroski F-Score | 6 |